MindWalk Holdings (HYFT) Share-based Compensation (2023 - 2026)
MindWalk Holdings' (HYFT) quarterly Share-based Compensation came in at $590899.9 in Q2 2026, up 1486.54% year-over-year from $37244.6 in Q2 2025, and up 16174365.78% quarter-over-quarter from $3.65 in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Share-based Compensation (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Share-based Compensation for 4 consecutive years, with $590899.9 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 1486.54% year-over-year to $590899.9 in Q2 2026; TTM through Apr 2026 was $1.3 million, a 289.16% increase from a year earlier, with the FY2026 full-year figure at $924005.8, up 189.24% from the prior year.
- Share-based Compensation was $590899.9 for Q2 2026 at MindWalk Holdings, up from $3.65 in the prior quarter.
- Over five years, Share-based Compensation peaked at $662284.6 in Q3 2025 and troughed at $3.65 in Q1 2026.
- A 4-year average of $237888.3 and a median of $137379.8 in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation plunged 100.0% in 2025 and soared 1486.54% in 2026, its largest moves.
- Over 4 years, Share-based Compensation stood at $219035.7 in 2023, then tumbled by 47.51% to $114969.3 in 2024, then sank by 100.0% to $5.03 in 2025, then jumped by 11743360.8% to $590899.9 in 2026.
- The last three Share-based Compensation figures came in at $590899.9 (Q2 2026), $3.65 (Q1 2026), and $5.03 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 95.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 4.35 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 19.78 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 18.46 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 12.60 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 7.60 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 357,000.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 590,899.88 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 590,899.88 |
| Jan 31, 2026 | 3.65 |
| Oct 31, 2025 | 5.03 |
| Jul 31, 2025 | 662,284.65 |
| Apr 30, 2025 | 37,244.62 |
| Jan 31, 2025 | 49,309.88 |
| Oct 31, 2024 | 114,969.33 |
| Jul 31, 2024 | 120,501.48 |
| Apr 30, 2024 | 174,792.31 |
| Jan 31, 2024 | 131,670.42 |
| Oct 31, 2023 | 219,035.68 |
| Jul 31, 2023 | 616,594.73 |
| Apr 30, 2023 | 470,035.28 |
| Jan 31, 2023 | 143,089.12 |